221 related articles for article (PubMed ID: 11148475)
1. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
Osella-Abate S; Zaccagna A; Savoia P; Quaglino P; Salomone B; Bernengo MG
J Am Acad Dermatol; 2001 Jan; 44(1):40-7. PubMed ID: 11148475
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection.
Boudet F; Lecoeur H; Gougeon ML
J Immunol; 1996 Mar; 156(6):2282-93. PubMed ID: 8690919
[TBL] [Abstract][Full Text] [Related]
4. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.
Bariş YS; Yildiz L; Sentürk N; Kandemir B
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710
[TBL] [Abstract][Full Text] [Related]
5. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
[TBL] [Abstract][Full Text] [Related]
6. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
[TBL] [Abstract][Full Text] [Related]
7. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
10. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
[TBL] [Abstract][Full Text] [Related]
11. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
[TBL] [Abstract][Full Text] [Related]
12. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
13. In vitro cell death of activated lymphocytes in Omenn's syndrome.
Brugnoni D; Airò P; Facchetti F; Blanzuoli L; Ugazio AG; Cattaneo R; Notarangelo LD
Eur J Immunol; 1997 Nov; 27(11):2765-73. PubMed ID: 9394797
[TBL] [Abstract][Full Text] [Related]
14. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
16. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
Kim JW; Tsukishiro T; Johnson JT; Whiteside TL
Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413
[TBL] [Abstract][Full Text] [Related]
17. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
18. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
[TBL] [Abstract][Full Text] [Related]
19. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
Dworacki G; Meidenbauer N; Kuss I; Hoffmann TK; Gooding W; Lotze M; Whiteside TL
Clin Cancer Res; 2001 Mar; 7(3 Suppl):947s-957s. PubMed ID: 11300496
[TBL] [Abstract][Full Text] [Related]
20. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
